Guidelines
Coronavirus Disease (COVID-19)

Coronavirus Disease (COVID-19)

Note

OSAT Recommendations

Please note, the Ontario COVID-19 Science Advisory Table (OSAT) will be disassembling effective September 6, 2022. As such, any prior OSAT recommendations are subject to change with new evidence and should be used with clinical discretion and judgement.

COVID-19 Evidence-Based Therapeutic Management

Moderately to Critically Ill

Mildly Ill (Higher Risk) - Select 1 of the following:

Anticoagulation

More Information

Please refer to the Ontario COVID-19 Science Advisory Table website for more details

Please note that TBRHSC COVID-19 therapeutic management recommendations are based on the Ontario COVID-19 Drugs and Biologics Clinical Practice Guidelines Working Group (on behalf of the Ontario COVID-19 Science Advisory Table-OSAT) and may change as additional data and information become available